The Interaction of Classical Complement Component C1 with Parasite and Host Calreticulin Mediates Trypanosoma cruzi Infection of Human Placenta

PLoS Neglected Tropical Diseases

Volumn 7, Issue 8, 2013, Pages

  Castillo, Christian ^a   Ramírez, Galia ^b   Valck, Carolina ^a   Aguilar, Lorena ^a   Maldonado, Ismael ^a   Rosas, Carlos ^a   Galanti, Norbel ^a   Kemmerling, Ulrike ^a   Ferreira, Arturo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; COMPLEMENT COMPONENT C1; IMMUNOGLOBULIN F (AB') 2 FRAGMENT; UNCLASSIFIED DRUG;

ARTICLE; CHAGAS DISEASE; CHORION VILLUS SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARASITE LOAD; PLACENTA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INJURY; TRYPANOSOMA CRUZI; WESTERN BLOTTING;

EID: 84883418236     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002376     Document Type: Article

References (80)

1. Chagas C, (1909) Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1: 159-218.
2. Moncayo A, (2003) Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98: 577-591.
3. Dias JC, Silveira AC, Schofield CJ, (2002) The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97: 603-612.
4. WHO (2012) Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. Technical report series.
5. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR, (2008) The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300.
6. Coura JR, Vinas PA, (2010) Chagas disease: a new worldwide challenge. Nature 465: S6-7.
7. Castro JA, Diaz de Toranzo EG, (1988) Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). Biomed Environ Sci 1: 19-33.
8. Yoshida N, Cortez M, (2008) Trypanosoma cruzi: parasite and host cell signaling during the invasion process. Subcell Biochem 47: 82-91.
9. Araya JE, Cornejo A, Orrego PR, Cordero EM, Cortez M, et al. (2008) Calcineurin B of the human protozoan parasite Trypanosoma cruzi is involved in cell invasion. Microbes Infect 10: 892-900.
10. Ramos R, Juri M, Ramos A, Hoecker G, Lavandero S, et al. (1991) An immunogenetically defined and immunodominant Trypanosoma cruzi antigen. Am J Trop Med Hyg 44: 314-322.
11. Aguillon JC, Bustos C, Vallejos P, Hermosilla T, Morello A, et al. (1995) Purification and preliminary sequencing of Tc-45, an immunodominant Trypanosoma cruzi antigen: absence of homology with cruzipain, cruzain, and a 46-kilodalton protein. Am J Trop Med Hyg 53: 211-215.
12. Aguillon JC, Ferreira L, Perez C, Colombo A, Molina MC, et al. (2000) Tc45, a dimorphic Trypanosoma cruzi immunogen with variable chromosomal localization, is calreticulin. Am J Trop Med Hyg 63: 306-312.
13. Ferreira V, Valck C, Sanchez G, Gingras A, Tzima S, et al. (2004) The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J Immunol 172: 3042-3050.
14. Molina MC, Ferreira V, Valck C, Aguilar L, Orellana J, et al. (2005) An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis. Mol Biochem Parasitol 140: 133-140.
15. Lopez NC, Valck C, Ramirez G, Rodriguez M, Ribeiro C, et al. (2010) Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin. PLoS Negl Trop Dis 4: e730.
16. Ramirez G, Valck C, Molina MC, Ribeiro CH, Lopez N, et al. (2011) Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 216: 265-273.
17. Rimoldi MT, Tenner AJ, Bobak DA, Joiner KA, (1989) Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J Clin Invest 84: 1982-1989.
18. Ramirez G, Valck C, Ferreira VP, Lopez N, Ferreira A, (2011) Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay. Trends Parasitol 27: 115-122.
19. Valck C, Ramirez G, Lopez N, Ribeiro CH, Maldonado I, et al. (2010) Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Mol Immunol 47: 1516-1521.
20. Robbins JR, Bakardjiev AI, (2012) Pathogens and the placental fortress. Curr Opin Microbiol 15: 36-43.
21. Zeldovich VB, Bakardjiev AI, (2012) Host defense and tolerance: unique challenges in the placenta. PLoS Pathog 8: e1002804.
22. Robbins JR, Zeldovich VB, Poukchanski A, Boothroyd JC, Bakardjiev AI, (2012) Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun 80: 418-428.
23. Lecuit M, Nelson DM, Smith SD, Khun H, Huerre M, et al. (2004) Targeting and crossing of the human maternofetal barrier by Listeria monocytogenes: role of internalin interaction with trophoblast E-cadherin. Proc Natl Acad Sci U S A 101: 6152-6157.
24. Delorme-Axford E, Coyne CB, (2011) The actin cytoskeleton as a barrier to virus infection of polarized epithelial cells. Viruses 3: 2462-2477.
25. Nelson WJ, (2009) Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. Cold Spring Harb Perspect Biol 1: a000513.
26. Stavru F, Bouillaud F, Sartori A, Ricquier D, Cossart P, (2011) Listeria monocytogenes transiently alters mitochondrial dynamics during infection. Proc Natl Acad Sci U S A 108: 3612-3617.
27. Diaz-Lujan C, Triquell MF, Schijman A, Paglini P, Fretes RE, (2012) Differential susceptibility of isolated human trophoblasts to infection by Trypanosoma cruzi. Placenta 33: 264-270.
28. Redline RW, Lu CY, (1987) Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest 79: 1234-1241.
29. Ferro EA, Silva DA, Bevilacqua E, Mineo JR, (2002) Effect of Toxoplasma gondii infection kinetics on trophoblast cell population in Calomys callosus, a model of congenital toxoplasmosis. Infect Immun 70: 7089-7094.
30. Zeldovich VB, Robbins JR, Kapidzic M, Lauer P, Bakardjiev AI, (2011) Invasive extravillous trophoblasts restrict intracellular growth and spread of Listeria monocytogenes. PLoS Pathog 7: e1002005.
31. Ross AL, Cannou C, Barre-Sinoussi F, Menu E, (2009) Proteasome-independent degradation of HIV-1 in naturally non-permissive human placental trophoblast cells. Retrovirology 6: 46.
32. Onderdonk AB, Hecht JL, McElrath TF, Delaney ML, Allred EN, et al. (2008) Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol 199: 52 e51-52 e10.
33. Cardenas I, Means RE, Aldo P, Koga K, Lang SM, et al. (2010) Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol 185: 1248-1257.
34. Duaso J, Rojo G, Cabrera G, Galanti N, Bosco C, et al. (2010) Trypanosoma cruzi induces tissue disorganization and destruction of chorionic villi in an ex vivo infection model of human placenta. Placenta 31: 705-711.
35. Duaso J, Rojo G, Jana F, Galanti N, Cabrera G, et al. (2011) Trypanosoma cruzi induces apoptosis in ex vivo infected human chorionic villi. Placenta 32: 356-361.
36. Duaso J, Yanez E, Castillo C, Galanti N, Cabrera G, et al. (2012) Reorganization of extracellular matrix in placentas from women with asymptomatic chagas disease: mechanism of parasite invasion or local placental defense? J Trop Med 2012: 758357.
37. Castillo C, Lopez-Munoz R, Duaso J, Galanti N, Jana F, et al. (2012) Role of matrix metalloproteinases 2 and 9 in ex vivo Trypanosoma cruzi infection of human placental chorionic villi. Placenta 33: 991-997.
38. Cross JC, (2005) How to make a placenta: mechanisms of trophoblast cell differentiation in mice-a review. Placenta 26 (Suppl A):: S3-9.
39. Rossant J, Cross JC, (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538-548.
40. Andrade SG, (1982) The influence of the strain of Trypanosoma cruzi in placental infections in mice. Trans R Soc Trop Med Hyg 76: 123-128.
41. Alkmim-Oliveira SM, Costa-Martins AG, Kappel HB, Correia D, Ramirez LE, et al. (2012) Trypanosoma cruzi experimental congenital transmission associated with TcV and TcI subpatent maternal parasitemia. Parasitol Res 112: 671-8.
42. Berniscke K, Kaufmann P., Baergen RN. (2006) Pathology of the human placenta. New York: Springer. 1069 p.
43. Aguilar L, Ramirez G, Valck C, Molina MC, Rojas A, et al. (2005) F(ab′)2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Biol Res 38: 187-195.
44. Ribeiro CH, Lopez NC, Ramirez GA, Valck CE, Molina MC, et al. (2009) Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Mol Immunol 46: 1092-1099.
45. Cummings KL, Tarleton RL, (2003) Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol 129: 53-59.
46. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
47. Hojrup P, Roepstorff P, Houen G, (2001) Human placental calreticulin characterization of domain structure and post-translational modifications. Eur J Biochem 268: 2558-2565.
48. Klaffenbach D, Friedrich D, Strick R, Strissel PL, Beckmann MW, et al. (2011) Contribution of different placental cells to the expression and stimulation of antimicrobial proteins (AMPs). Placenta 32: 830-837.
49. Koi H, Zhang J, Parry S, (2001) The mechanisms of placental viral infection. Ann N Y Acad Sci 943: 148-156.
50. Halwachs-Baumann G, (2006) The congenital cytomegalovirus infection: virus-host interaction for defense and transmission. Curr Pharm Biotechnol 7: 303-312.
51. Dische MR, Quinn PA, Czegledy-Nagy E, Sturgess JM, (1979) Genital mycoplasma infection. Intrauterine infection: pathologic study of the fetus and placenta. Am J Clin Pathol 72: 167-174.
52. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW, (2007) Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 7: 105-117.
53. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93-104.
54. Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD, (2007) Schistosomiasis and pregnancy. Trends Parasitol 23: 159-164.
55. Biedermann K, Flepp M, Fierz W, Joller-Jemelka H, Kleihues P, (1995) Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med 23: 191-203.
56. Correa D, Canedo-Solares I, Ortiz-Alegria LB, Caballero-Ortega H, Rico-Torres CP, (2007) Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol 29: 651-660.
57. Rocha G, Martins A, Gama G, Brandao F, Atouguia J, (2004) Possible cases of sexual and congenital transmission of sleeping sickness. Lancet 363: 247.
58. Guilbert L, Robertson SA, Wegmann TG, (1993) The trophoblast as an integral component of a macrophage-cytokine network. Immunol Cell Biol 71 (Pt 1):: 49-57.
59. Lin S, Sartori MJ, Mezzano L, de Fabro SP, (2005) Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas' disease. Placenta 26: 789-795.
60. Ghebrehiwet B, Peerschke EI, (2004) cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol 41: 173-183.
61. Sartori MJ, Pons P, Mezzano L, Lin S, de Fabro SP, (2003) Trypanosoma cruzi infection induces microfilament depletion in human placenta syncytiotrophoblast. Placenta 24: 767-771.
62. Shippey SH, (2005) Use of the placental perfusion model to evaluate transplacental passage of Trypanosoma cruzi. Am J Obstet Gynecol 192: 586-591.
63. Santana JM, Grellier P, Schrevel J, Teixeira AR, (1997) A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J 325 (Pt 1):: 129-137.
64. Marino AP, Silva AA, Pinho RT, Lannes-Vieira J, (2003) Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules. Braz J Med Biol Res 36: 1121-1133.
65. Geurts N, Opdenakker G, Van den Steen PE, (2012) Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. Pharmacol Ther 133: 257-279.
66. Sartori MJ, Lin S, Frank FM, Malchiodi EL, de Fabro SP, (2002) Role of placental alkaline phosphatase in the interaction between human placental trophoblast and Trypanosoma cruzi. Exp Mol Pathol 72: 84-90.
67. Virreira M, Truyens C, Alonso-Vega C, Brutus L, Jijena J, et al. (2007) Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am J Trop Med Hyg 77: 102-106.
68. Mezzano L, Sartori MJ, Lin S, Repossi G, de Fabro SP, (2005) Placental alkaline phosphatase (PLAP) study in diabetic human placental villi infected with Trypanosoma cruzi. Placenta 26: 85-92.
69. Sartori MJ, Mezzano L, Lin S, Repossi G, Fabro SP, (2005) [Cellular components and placental alkaline phosphatase in Trypanosoma cruzi infection]. Rev Soc Bras Med Trop 38 (Suppl 2):: 87-91.
70. Chan G, Guilbert LJ, (2006) Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J Pathol 210: 111-120.
71. Maubert B, Guilbert LJ, Deloron P, (1997) Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect Immun 65: 1251-1257.
72. Abbasi M, Kowalewska-Grochowska K, Bahar MA, Kilani RT, Winkler-Lowen B, et al. (2003) Infection of placental trophoblasts by Toxoplasma gondii. J Infect Dis 188: 608-616.
73. Marcelain K, Colombo A, Molina MC, Ferreira L, Lorca M, et al. (2000) Development of an immunoenzymatic assay for the detection of human antibodies against Trypanosoma cruzi calreticulin, an immunodominant antigen. Acta Trop 75: 291-300.
74. Lacroix M, Dumestre-Perard C, Schoehn G, Houen G, Cesbron JY, et al. (2009) Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J Immunol 182: 456-465.
75. Apt W, Naquira C, Strozzi L, (1968) [Congenital transmission of trypanosomiasis cruzi. 3. In mice with acute and chronic infection]. Bol Chil Parasitol 23: 15-19.
76. Carlier Y, Rivera MT, Truyens C, Goldman M, Lambert P, et al. (1987) Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi. Infect Immun 55: 2496-2501.
77. de Cunio RW, Olmos JA, de Mercau TN, Blanca RL, de Marteau DF, et al. (1980) [Experimental congenital Chagas-Mazza disease]. Medicina (B Aires) 40 (Suppl 1):: 50-55.
78. Johnson CA, Kleshchenko YY, Ikejiani AO, Udoko AN, Cardenas TC, et al. (2012) Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection. PLoS One 7: e40614.
79. Chen H, Herndon ME, Lawler J, (2000) The cell biology of thrombospondin-1. Matrix Biol 19: 597-614.
80. Ostankova YV, Klimovskaya YS, Gorskaya OA, Kolobov AV, Kvetnoi IM, et al. (2011) Expression of thrombospondin-1 gene mRNA and protein in the placenta in gestosis. Bull Exp Biol Med 151: 215-218.